Medical statistics

Cannabis Market Flourishes Amid Global Legalization, Driving Concerns About Road Safety

Retrieved on: 
Monday, April 22, 2024
NGC, Financial News, Forensic Medicine Division, Medical laboratory, Workplace, Growth, Medical statistics, Legislation, Public opinion, Cannabinoid, Control, Pharmacokinetics, OTC, ACB, Chocolate, Cannabis, GACP, Edible, Curaleaf, Safety, THC, Certification, Health, Canopy Growth, Collection, Injury, Medical jurisprudence, Offense, IACT, CGC, Lord, Division, USD, University, Vital statistics, OTCQX, Tracking system, International Association, Patient, Principal, College, The College of Medicine, Drug

NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Over the past decade, the cannabis market has undergone significant expansion, driven largely by a wave of legalization efforts across the United States and other parts of the world. As state and national governments reassess their legal stance on cannabis, both for medical and recreational use, the industry has seen a surge in legitimacy and economic interest. In the United States, a majority of states have legalized cannabis in some form, reflecting a shift in public opinion and an acknowledgement of the potential medical benefits and revenue generation opportunities. Globally, countries like Canada, Uruguay, and several European nations have moved towards more liberal cannabis policies, further propelling the market's growth. The financial implications of these legalization efforts are substantial and continue to evolve. According to a report by Grand View Research, the global legal cannabis market size was valued at USD 13.2 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 25.5% from 2022 to 2030. Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), Cronos Group Inc. (NASDAQ: CRON), Canopy Growth Corporation (NASDAQ: CGC), Aurora Cannabis Inc. (NASDAQ: ACB), Curaleaf Holdings, Inc. (OTC: CURLF)

Key Points: 
  • Globally, countries like Canada, Uruguay, and several European nations have moved towards more liberal cannabis policies, further propelling the market's growth.
  • One of the primary concerns is the correlation between cannabis use and impaired driving.
  • Studies have shown that cannabis can significantly impair motor coordination, reaction times, and decision making, which are critical skills for safe driving.
  • NGC also partners with Canadian GACP cultivators to produce and distribute finished cannabis products to both the domestic and global markets.

Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California

Retrieved on: 
Monday, April 22, 2024
University, Vital statistics, Safety, Pharmacokinetics, Tracking system, OTC, Forensic Medicine Division, Collection, Medical laboratory, Injury, Medical jurisprudence, International Association, Medical statistics, Principal, Legislation, College, IACT, Cannabinoid, The College of Medicine, Control, Division

VANCOUVER, British Columbia, April 22, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace reports that it will be presenting at the International Association for Chemical Testing (IACT) conference in April.

Key Points: 
  • VANCOUVER, British Columbia, April 22, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace reports that it will be presenting at the International Association for Chemical Testing (IACT) conference in April.
  • Cannabix’s Dr. Bruce Goldberger Ph.D., will be presenting on Science & Technology Behind Cannabis Breath Testing and the Company’s marijuana breathalyzer system at the conference workshop session.
  • IACT is composed of governmental agency personnel involved in chemical testing related to traffic safety.
  • IACT has standing committees to address various areas including legislation, training, new equipment and procedures and manufacturers of breath testing equipment.

Global Non-meat Ingredients Industry Research 2024-2029: Technological Advancements to Develop New Product Lines, Growth of Indian Processed Market, & Rising Demand from Fast-Food Chains - ResearchAndMarkets.com

Retrieved on: 
Friday, April 26, 2024
Food, Beverage, Retail, USD, Food safety, Associated British Foods, Social media, Safety, Travel, Statistics, BASF, Prevalence, Cargill, Taste, Growth, Form, Medical statistics, Convenience food, Region, Benchmarking, DSM, Chemical substance, ADM, Food court, Meat, Kerry Group, Fast food

As consumers become more adventurous in their food choices, the demand for non-meat ingredients has increased rapidly.

Key Points: 
  • As consumers become more adventurous in their food choices, the demand for non-meat ingredients has increased rapidly.
  • These ingredients play a crucial role in enhancing the flavor, texture, and overall quality of processed meat products.
  • Plant-derived ingredients may have limited availability, seasonality, and variability in quality, while animal-derived ingredients may pose ethical and cultural concerns.
  • The prevalence of large fast-food chains further drives the demand for processed meat products in the US market.

Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID

Retrieved on: 
Tuesday, March 26, 2024
Fibromyalgia, DSM-IV codes, Epstein–Barr virus, WIPO, COVID-19, Patient, Conditional sentence, Orthostatic intolerance, System, Celecoxib, Anxiety, Medical statistics, EBV, MD, Fatigue, Treatment, Therapy, Patent, Pain, Valaciclovir, FDA, Pharmaceutical industry

ATLANTA, March 26, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“FM”) and Long-COVID (“LC”), today announced that the World Intellectual Property Organization (WIPO) has published Virios’ global patent application titled “Valacyclovir and Celecoxib for the Treatment of Alzheimer’s and COVID-19”, which covers the use of IMC-2, a proprietary combination of valacyclovir and celecoxib. This milestone enables Virios to streamline the process for obtaining patent protection globally, representing a precursor to the national phase of patent examination by targeted countries across the globe.

Key Points: 
  • This milestone enables Virios to streamline the process for obtaining patent protection globally, representing a precursor to the national phase of patent examination by targeted countries across the globe.
  • An open-label, exploratory LC study sponsored by Virios demonstrated that treatment with the combination of valacyclovir and celecoxib resulted in clinical and statistically significant reductions in LC associated fatigue, orthostatic intolerance, pain and anxiety.
  • Previous estimates suggest that up to 10 million children in the US have also experienced LC.
  • There are no treatments approved by the FDA to treat the symptoms associated with LC, further highlighting the need for new treatments.

Data Equity Advocate Ninez A. Ponce Receives 2024 Elizabeth Fries Health Education Award

Retrieved on: 
Wednesday, March 20, 2024
Health promotion, Health equity, Health, Equity, Society, Psychology, Population health, Research, Diversity, Policy, Health policy, Native Hawaiians, Social insurance, MPP, Teaching, Organization, Stanford Cancer Institute, Memory, National Quality Forum, Public, MD, Student, Health care, Public health, Virginia Commonwealth University, Medical statistics, Doctor of Philosophy, Faculty, Milbank Quarterly, Data collection, CDC, Lecture, National academy, Health education, Nursing

ATLANTA, March 20, 2024 /PRNewswire/ -- Ninez A. Ponce, PhD, MPP, distinguished public health researcher, today received the 2024 Elizabeth Fries Health Education Award.

Key Points: 
  • ATLANTA, March 20, 2024 /PRNewswire/ -- Ninez A. Ponce, PhD, MPP, distinguished public health researcher, today received the 2024 Elizabeth Fries Health Education Award.
  • This year's award was presented to Ponce at the annual meeting of the Society for Public Health Education (SOPHE), along with her lecture entitled "No Equity without Data Equity."
  • The Elizabeth Fries Health Education Award, first presented in 1992, recognizes a health educator who has made a substantial contribution to advancing the field of health education or health promotion through research, program development or program delivery.
  • As of 2016, the CDC Foundation manages and administers the Fries Foundation's public health award programs, which include the Fries Prize for Improving Health and the Elizabeth Fries Health Education Award.

Introducing Emma Up: A Revolutionary Sleep Solution Powered By Action-Oriented AI Coaching

Retrieved on: 
Friday, March 1, 2024
Google Play, AI, Research, MD, Temperature, App Store (iOS/iPadOS), Sleep, Medical statistics, NCHS, Habit, University of Oxford, Stanford University, Ageing, Pharmaceutical industry

NEW YORK, March 1, 2024 /PRNewswire/ -- Emma Up, the AI sleep coaching app created by Emma - The Sleep Company (the world's largest D2C sleep brand), is excited to announce the launch of its new sound-based sleep tracking feature. This innovative addition utilizes AI technology to offer users comprehensive insights into their sleep patterns and lifestyle habits without the need for any additional devices.

Key Points: 
  • Emma Up, a revolutionary AI sleep coaching app, launches a new sound-based sleep tracking function providing users with personalized lifestyle insights and actionable next steps for improving sleep quality.
  • NEW YORK, March 1, 2024 /PRNewswire/ -- Emma Up, the AI sleep coaching app created by Emma - The Sleep Company (the world's largest D2C sleep brand), is excited to announce the launch of its new sound-based sleep tracking feature.
  • Developed in collaboration with sleep experts from Oxford University, Emma Up stands as the most advanced sleep app on the market.
  • [3]
    Additionally, Emma Up acts as an AI sleep coach and pioneers that technology: expect hyper-personalized programs tailored to each user's unique sleep patterns, habits, and lifestyle.

National Safety Council Estimates Traffic Crashes Took More Than 44,000 Lives in 2023

Retrieved on: 
Monday, February 26, 2024
Crash, Medical statistics, Death, Safety, School, NSC, Element, Council, National Safety Council, CDC, Transport, Atrocity, Travel, Road

WASHINGTON, Feb. 26, 2024 /PRNewswire/ -- Preliminary analysis from the National Safety Council shows motor vehicle fatalities in the United States remain at a devastatingly high level, as an estimated 44,450 people died in traffic crashes in 2023. While it marks a 4% decline from 2022, compared to pre-pandemic 2019, it's a 13.6% uptick, further demonstrating the seriousness of this public health crisis.

Key Points: 
  • WASHINGTON, Feb. 26, 2024 /PRNewswire/ -- Preliminary analysis from the National Safety Council shows motor vehicle fatalities in the United States remain at a devastatingly high level, as an estimated 44,450 people died in traffic crashes in 2023 .
  • Safety issues such as speeding, distracted and impaired driving are all contributing factors to the tens of thousands of people lost in preventable crashes on U.S. roads each year.
  • Embracing the Safe System Approach at national, state and local levels is a critical step toward eliminating traffic fatalities nationwide.
  • The National Safety Council has calculated traffic fatality estimates since 1913.

Prevent Blindness Launches New "Retinopathy of Prematurity (ROP) Education and Support Program" as Part of Inaugural ROP Awareness Week, Feb. 26 - March 3, 2024

Retrieved on: 
Wednesday, February 21, 2024
Education, Medical director, Medical statistics, Parent, Infant, Pregnancy, University, Organization, Retinopathy, Diagnosis, Gestational age, Head, Social media, Section, Mental health, MBA, Associate professor, MSC, Initiative, Doctor of Psychology, Distribution, Partnership, FACS, National Eye Institute, Ear, University of Illinois Urbana-Champaign, Paratriathlon, ROP, Visual impairment, Safety, Division, MD, Visual Science, Diversity, Patient, Nursing

CHICAGO, Feb. 21, 2024 /PRNewswire-PRWeb/ -- Prevent Blindness, the nation's leading eye health and safety nonprofit organization, has launched the new "Retinopathy of Prematurity Education and Support Program," as part of its first ROP Awareness Week, declared Feb. 26 – March 3, 2024. The group is offering a variety of free educational resources to the public and professionals, including fact sheets, social media graphics in English and Spanish, dedicated online resources, and a new video series.

Key Points: 
  • "Diagnosing and treating ROP early is essential for preventing or lessening ROP-associated vision loss," said Jeff Todd, president and CEO of Prevent Blindness.
  • To help address the need for ROP awareness and education, Prevent Blindness convened leading organizations in the parent support, education, and advocacy arenas to partner on creating the ROP Education and Support Program.
  • The ROP Education and Support Program and ROP Awareness Week is supported by funding from Regeneron .
  • In the Prevent Blindness Focus on Eye Health Expert Series, " Retinopathy of Prematurity ," Jeff Todd, president and CEO of Prevent Blindness, interviews R.V.

Virios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVID

Retrieved on: 
Tuesday, January 2, 2024
PASC, Orthostatic intolerance, Food, Medical statistics, FDA, Disease, Conditional sentence, Fatigue, Therapy, Fibromyalgia, Vaccine

The FDA agreed that for the planned Phase 2 proof-of-concept study, Virios can use fatigue as the primary endpoint and orthostatic intolerance as a key secondary endpoint to assess the effectiveness of IMC-2 in treating PASC.

Key Points: 
  • The FDA agreed that for the planned Phase 2 proof-of-concept study, Virios can use fatigue as the primary endpoint and orthostatic intolerance as a key secondary endpoint to assess the effectiveness of IMC-2 in treating PASC.
  • The FDA recommended assessment of a range of IMC-2 doses, including valacyclovir doses above presently approved dosage strengths, to ensure effective inhibition of reactivated herpesvirus.
  • Following the receipt of the FDA’s feedback, Virios is currently exploring options to advance the IMC-2 LC Phase 2 research program.
  • IMC-2 has the potential to be one of the first approved treatments specifically for LC.

National Safety Council Estimates 21,150 People Died on U.S. Roads in First Half of 2023

Retrieved on: 
Wednesday, August 23, 2023
National Center for Health Statistics, U.S. Department of Defense Strategy for Operating in Cyberspace, Friends, Integrated safe system of work, Hope, Transport, NSC, Death, Crash, National Safety Council, Medical statistics, Fatality, Safety, Road

WASHINGTON, Aug. 23, 2023 /PRNewswire/ -- Preliminary estimates released by the National Safety Council show traffic deaths in the U.S. are on a slight decline through the first six months of 2023, as compared to the same period in 2022. From January 2023 through June 2023, an estimated 21,150 people died in preventable motor vehicle crashes in the United States, down 3% from the first six months of last year.

Key Points: 
  • From January 2023 through June 2023, an estimated 21,150 people died in preventable motor vehicle crashes in the United States, down 3% from the first six months of last year.
  • "While there is a glimmer of hope that progress is being made, these estimates are still a stark reminder of the work that lies ahead," said Mark Chung, executive vice president of roadway practice at the National Safety Council.
  • The estimates further underscore the urgent need for continued efforts to improve road safety across the nation through the implementation of the Safe System approach ."
  • NSC motor vehicle fatality estimates and supplemental estimate information, including estimates for each state, can be found here .